Advanced Neuromodulation Systems receives European approval
for pain-control device
18 January 2006 Plano, Texas, USA. Advanced Neuromodulation Systems (ANS),
the neuromodulation business of St. Jude Medical, Inc. (NYSE:STJ), has
received European CE Mark approval for its spinal cord stimulation (SCS)
device for managing chronic pain. The Rapid Programmer 3.0 features two
new technologies for delivering stimulation to pain patients:
- Dynamic MultiStim, which allows for real-time adjustments to
multiple areas of pain. This is especially useful when patients have
complex pain patterns, such as a combination of back and leg pain.
- Active Balancing enables fine tuning of stimulation levels in
multiple coverage areas.
Coinciding with this approval, ANS has launched an upgraded version
of its rechargeable spinal cord stimulation device, the Eon with
NeuroDynamix technology. Spinal cord stimulators like Eon are used to
treat patients suffering with chronic intractable pain. These
“pacemakers for pain” interrupt the pain signals’ pathway to the brain
by delivering low intensity electrical pulses to selective nerve fibres
along the spinal cord. More than 30,000 patients worldwide have been
implanted with ANS neurostimulation systems to help alleviate their
chronic pain. “The enhanced Eon and the new Rapid Programmer platform
work together as an integrated system to provide clinicians greater
speed, power, efficiency and precision for helping patients address
complex pain,” said Chris Chavez, president of Advanced Neuromodulation
Systems. To top
|
